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In Brief
Loss of progranulin, which occurs in patients with frontotemporal dementia, causes lysosomal defects and excessive complement production, triggering selective synaptic pruning by microglia and behavioral deficits that can be rescued by blocking complement activation.
INTRODUCTION
Microglia are innate immune cells that repair injury and maintain homeostasis in the CNS (Ransohoff and Perry, 2009) . Previous studies indicate that microglia employ a diverse repertoire of proteins in the innate immune system to regulate synapse formation and maintenance. For example, in early postnatal life, microglia use the classical complement pathway to regulate synapse development in the lateral geniculate nucleus (Schafer et al., 2012; Stevens et al., 2007) . During the aging process, however, progressive accumulation of complement C1qa in the dentate gyrus of hippocampus promotes cognitive decline and memory impairments (Stephan et al., 2013) . In contrast, loss of complement C3 protein protects against age-dependent declines in synaptic and dendritic spine density in the CA3 region of the hippocampus and rescues attenuation of long-term potentiation (LTP) (Shi et al., 2015) . In addition, microglia also use fractalkine receptor CX3CR1 to regulate the growth and maintenance of dendritic spines on hippocampal neurons, which in turn serve as the structural basis of synapse formation (Paolicelli et al., 2011) . Finally, genetic ablation of microglia in the adult brain further reveals the essential role of microglia in the maintenance of synaptic functions and motor learning (Parkhurst et al., 2013) . Given these results, it has been proposed that excessive microglial activation may contribute to the pathogenesis of neurodegenerative diseases (Aguzzi et al., 2013) . However, whether microglial activation directly contributes to neurodegeneration remains unclear.
In this study, we investigate the role of aberrant microglial activation as the primary pathogenic factor for frontotemporal dementia (FTD), the second most common dementia affecting patients younger than 65 years of age (Rascovsky et al., 2011; Ratnavalli et al., 2002) . We focus on the autosomal dominant mutations in the human progranulin (GRN) gene, which cause a drastic reduction in progranulin (PGRN) levels, contributing to the pathogenesis of one the most common forms of familial frontotemporal lobar degeneration (FTLD) (Baker et al., 2006; Cruts et al., 2006; Finch et al., 2009; Ghidoni et al., 2008; Sleegers et al., 2009) . Several studies indicate that PGRN is a key regulator of inflammation and that PGRN deficiency causes an aberrant increase in phagocytosis and pro-inflammatory cytokine production in microglia and macrophages (Kao et al., 2011; Martens et al., 2012; Yin et al., 2010) . Furthermore, when exposed to the neurotoxin MPTP, both global Grn knockout (Grn À/À ) and microglia-specific Grn knockout (Cd11b-Cre;Grn fl/fl ) mutant mice show a much more robust increase in microglial activation and neuronal loss (Martens et al., 2012) , supporting the idea that PGRN is required to suppress excessive microglial activation. Finally, rare homozygous GRN mutations in humans have been shown to cause neuronal ceroid lipofuscinosis (NCL), which shares similar neuropathological features with FTLD patients with GRN mutations (Gö tzl et al., 2014; Smith et al., 2012) . The connection between FTLD caused by GRN mutations and NCL is intriguing because neuroinflammation is a prominent and consistent feature in animal models of NCL and lysosomal storage diseases (Castaneda et al., 2008; Cotman et al., 2013) . Together, these data suggest that PGRN deficiency may lead to a spectrum of neurodegenerative conditions in a dose-dependent manner. Despite evidence supporting the role of PGRN in microglia function, it remains unclear how PGRN deficiency causes microglia activation and how PGRN-deficient microglia contribute to neurodegeneration in the aging brain. It is equally unclear whether blocking microglia activation in chronic PGRN deficiency could mitigate neurodegeneration. Here, we show that loss of PGRN causes an age-dependent upregulation of lysosomal and innate immunity genes in microglia, which increases complement production and synaptic pruning activity by microglia to preferentially eliminate inhibitory synapses in the ventral thalamus. These defects lead to hyperexcitability in the thalamocortical circuits and obsessive-compulsive disorder (OCD)-like grooming behaviors. Remarkably, blocking complement activation significantly reduces synaptic pruning by Grn À/À microglia and mitigates neurodegeneration, behavioral phenotypes, and premature mortality in Grn À/À mice. These results uncover a previously unrecognized role of PGRN in suppressing microglia activation and support an important conceptual advance that complement activation and microglia activation are major drivers, rather than consequences, of neurodegeneration caused by PGRN deficiency.
RESULTS
Transcriptional Profiling Reveals Age-Dependent Lysosomal and Innate Immunity Defects in Grn À/À
Microglia
To investigate how PGRN deficiency contributes to neurodegeneration during aging, we analyzed the transcriptomes of the cerebral cortex, hippocampus, and cerebellum in 2-, 6-, 9-, 12-, and 18-month-old Grn +/+ , Grn
, and Grn À/À mice. We used weighted correlation network analysis (WGCNA) to identify highly correlated gene modules that were either up-or downregulated in an age-dependent and genotype-specific manner ( Figure 1A ) (Langfelder and Horvath, 2008; Zhang and Horvath, 2005) . Principal component analyses showed no difference in the transcriptomes between Grn +/+ and Grn +/À brain regions, but revealed an age-dependent upregulation of one particular gene module in the cerebral cortex (magenta module) (Figure 1B) , hippocampus (purple module), and cerebellum (pink module) of Grn À/À mice ( Figure S1A ). DAVID gene ontology (GO) analyses of these modules revealed two major categories, the lytic vacuole genes in the lysosomal pathway and genes related to innate immune responses (Table S1 ). Compared to an independent cell-type enrichment dataset (Zhang et al., 2014) , genes in the magenta module (cerebral cortex) showed exclusive association with the microglial lineage (p = 6.52 3 10 À14 ) ( Figure 1C , inset). System-level analyses of the top 40 genes from magenta, purple, and pink modules revealed extensive topographical overlap ( Figures 1C, S1B , and S1C), supporting functional interactions among these genes. At the center of this interconnected network were complement genes (C1qa, C1qb, C1qc, and C3), CD68, and Trem2, which have been implicated in innate immunity, lysosomal function, and microglial activation (Wang et al., 2015) , respectively. These results are consistent with the cell-type enrichment transcriptome data, which shows that Grn mRNA is >50-fold enriched in microglia (>881.4 fragments per kilobase of exon per million fragments mapped [FPKM]) ( Figure S1D ) (Zhang et al., 2014) and support that microglia contribute to the age-dependent transcriptional upregulation of lysosomal and innate immunity genes in the aging Grn À/À brain.
To validate the brain region-specific transcriptome profiling results, we isolated microglia from 4-and 16-month-old Grn +/+ and Grn À/À mice using Percoll gradients and fluorescence-activated cell sorting (FACS) with microglia/macrophage/neutrophil markers, CD11b PE, CD45 APC, and anti-Ly6G PE-Cy7 (Figure 1D ). This approach revealed a 4-fold increase in the relative abundance of microglia (defined as CD45 lo ;CD11b + , pink gate in Figures 1E and 1F Figure 1E ). We then analyzed the transcriptional profiles of FACS-sorted 4-and 16-month-old Grn +/+ and Grn À/À microglia using principle component analysis of the top 500 most variable transcripts and showed that the 4-month-old Grn +/+ and Grn À/À microglia replicates clustered closely, suggesting that loss of PGRN had only modest effects on the transcriptional profiles of microglia at this age (Figure 1G) . In contrast, 16-month-old Grn À/À microglia showed much more profound alterations in transcriptional profiles than 16-month-old Grn +/+ microglia ( Figure 1G ). Hierarchical clustering analyses of the top 200 transcripts confirmed that the transcriptional profiles of Grn +/+ and Grn À/À microglia were similar at 4 months old, but became drastically different at 16 months old ( Figure 1H ). Together, these results support that PGRN is required to suppress aberrant microglial activation during aging.
Characterizations of PGRN in the Endolysosomal Pathway in Microglia
To characterize how microglia contribute to the upregulation of lysosomal and innate immune response genes in Grn À/À brain, we analyzed lysosomal morphology in the microglia of 4-and 18-month-old Grn +/+ and Grn À/À brains. Using CD68 as a marker for lysosomes and Iba-1 for microglia, we found that Grn À/À microglia showed a marked increase in lysosomal size at 18 months old (Figures 2A-2E ). Although microglia in 4-month-old Grn
and Grn À/À brains showed no difference in the lysosomal size, treatment with neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced a significant increase in the size of CD68 + lysosomes in Grn À/À microglia ( Figure 2E ). Similar MPTP-induced increase in lysosomal size was also detected in the microglia of Cd11b-Cre;Grn f/f mutants, suggesting that the , and Grn À/À mice during aging.
(B) Weighted correlation network analysis (WGCNA) identifies highly correlated gene modules that are age-dependently upregulated in the cerebral cortex of Grn À/À mice.
(C) The top 40 genes from the magenta (cerebral cortex) module are highly enriched with microglial genes (inset), and there is extensive topographical overlap among their expression patterns, especially for complements C1qa, C1qb, C1qc and C3, Cd68, and Trem2. (D) See also Figure S1 and we used bafilomycin A1 (5 nM), a vacuolar type H + -ATPase inhibitor, to block acidification and protein degradation in lysosomes (Yoshimori et al., 1991) . This treatment completely blocked DQ-BSA signals in Grn +/+ and Grn À/À microglia with no detectable differences ( Figure 2Q ).
Complement Protein C1qa Promotes Synaptic Pruning by Grn À/À Microglia
To investigate the functional consequences of the lysosomal defects in Grn À/À microglia, we asked whether this phenotype promotes activation of innate immunity and thereby promoting neurodegeneration. Among the innate immune response genes upregulated in Grn À/À brain, we focused on the complement system because complement-mediated synaptic pruning is a key mechanism in modulating neural circuit functions (Schafer et al., 2012; Stephan et al., 2013; Stevens et al., 2007) . Furthermore, aberrant lysosome-mediated cleavage of complement protein C3 induces proinflammatory cytokine production in T lymphocytes and contributes to the pathogenesis of autoimmune disease (Liszewski et al., 2013 Figures S3I-S3N ).
Given the marked increases in C1qa and C3 in Grn À/À microglia, we reasoned that increased complement production and upregulation of lysosomal genes might allow Grn À/À microglia to be more efficient in pruning synapses. To test this, we designed a co-culture system in which wild-type cortical neurons were plated at low density to allow uniform synapse development for 14 days in vitro (DIV14) ( Figure 3A ). Concurrently, microglia were cultured from Grn +/+ and Grn À/À neonatal brains and added to cortical neurons at 1:3 ratio at DIV14. The co-cultures continued for 3 more days before they were collected for immunostaining and analysis ( Figures  3B and 3C ). To show the effect of microglia in synaptic pruning, we used a modified Sholl analysis to quantify the amount synaptophysin + synapses around the cell body of microglia ( Figure 3C ). We also used the Imaris software to perform 3D reconstruction of confocal images to quantify the number of C1qa-tagged synapses and the number of synapses within the lysosomes of microglia.
In Grn +/+ microglia-neuron co-cultures, the synaptic density adjacent to the cell body of microglia was low, with progressive increase in areas distant from microglia ( Figures 3D and 3T , black line). Approximately 3% of synapses in Grn +/+ microglianeuron co-cultures were immediately adjacent to C1qa-positive signals (Figures 3E and 3F) , suggesting that these synapses were ''tagged'' by C1qa for removal. Indeed, several synapses were identified in CD68 + lysosomes within the cytoplasm of Grn +/+ microglia ( Figure 3G ). In contrast, the synaptic density surrounding Grn À/À microglia was significantly lower than that around Grn +/+ microglia ( Figures 3H and 3T , red line). Furthermore, there were more C1qa-positive synapses both outside Grn À/À microglia and within the CD68 + lysosomes inside Grn
In C1qa À/À microglia-neuron co-cultures, the synaptic density around microglia was much higher, especially within a 30-mm radius ( Figures 3L, 3M , and 3T, blue line). No C1qa was detected near or within the synapse, again supporting the idea that C1qa was made by microglia, not by neurons ( Figures 3N and 3U ). , C1qa À/À , and Grn À/À ;C1qa À/À microglia. ***p < 0.005, ****p < 0.001, two-way ANOVA, n = 4 for all genotypes.
(U and V) Quantification of the percentage of C1qa-tagged synapses outside microglia (U) and the number of SPH + synapse inside microglia (V). *p < 0.05, **p < 0.01, ***p < 0.005, Student's t test, n = 4 per genotype. See also Figure S3 .
mouse brains are more severely affected by the increases in complements and microglia and how this might contribute to neurodegeneration. To test this, we performed qRT-PCR using mRNA from cerebral cortex, hippocampus, caudate/putamen, cerebellum, and thalamus from 12-month-old Grn +/+ and Grn À/À brains and showed that C1qa and C3 mRNA were most abundant in the thalamus in Grn À/À brains, with an age-dependent increase ( Figures 4A-4D ). In addition, western blots showed that both C1qa and C3 cleavage product iC3b were age-dependently upregulated in the thalamus of Grn À/À mice ( Figures 4E and 4F ).
Given the role of complements in synaptic pruning, we asked whether C1qa and C3 were deposited near or at the synapses in vivo. To address this, we performed immunostains and showed very low C1qa signal in the ventral thalamus of Grn +/+ mice at 4 and 18 months old (Figures 4G and 4H) Figures 4Q-4V ). In addition, immunogold electron microscopy (IEM) showed that C1qa was immediately adjacent to synapses in Grn À/À thalamus, but not in Grn +/+ thalamus (Figures 4W and 4X) . Finally, to provide biochemical evidence for complement deposition at the synapses of Grn À/À mice, we used discontinuous sucrose gradient to isolate synaptosomes from 4-, 9-, and 16-month-old Grn +/+ and Grn À/À mouse brains (Carlin et al., 1980) and showed an age-dependent increase in C1qa and multiple C3 cleavage products in the synaptosomes from Grn À/À brain ( Figure 4Y ). ;C1qa À/À mice ( Figures S5E-S5I ).
Removing C1qa in Grn
To characterize how loss of inhibitory synapses in the ventral thalamus of Grn À/À mice might alter circuit function, we performed multiunit array extracellular recording in VPM and VPL in freshly prepared brain slices from 12-month-old Grn +/+ and Grn À/À mice ( Figure 6J ). This approach preserves an intact intra-thalamic circuit and has been instrumental in determining the thalamic function in rodents (Paz et al., 2011 (Paz et al., , 2013 . In the ventral thalamus of Grn +/+ mice, electrical stimulation of the internal capsule generated occasional bursts of action potentials (AP) ( Figure 6K ). In contrast, the same stimulation in the ventral thalamus of Grn À/À brain slices evoked a long-lasting and sustained tonic firing, with significant increase in AP firing frequency and the relative probability of eliciting AP (p < 0.0001) ( Figure 6L ). Remarkably, loss of C1qa in Grn (legend continued on next page) mice and restored the evoked firing pattern in the thalamus to a pattern similar to Grn +/+ mice ( Figures 6K and 6L ).
Dysfunction in the thalamus and striatum has been implicated in obsessive compulsive disorder (OCD), a key clinical feature in FTD (Fitzgerald et al., 2011; Rascovsky et al., 2011) . Consistent with hyperexcitability in the ventral thalamus, Grn À/À mice exhibited increased grooming activity, consisting of bouts of high-frequency repetitive movement that covered the snout, face, ear, and back (Movie S1). These excessive grooming behaviors began at 8 months old and persisted at 12 months old ( Figures 6M and S6A ). Due to excessive grooming, >60% of Grn À/À mice developed severe skin ulcerations. In addition, $10% of Grn À/À mice also developed motor dysfunction, including unsteady gait and imbalance (Movie S1). These two phenotypes contributed to the early mortality in Grn À/À mice (median survival for Grn À/À mice was 529 days, compared to 735 days in Grn +/+ mice, p < 0.0001, log rank [Mantel-Cox] test) ( Figures 6N and 6O ). In contrast, Grn À/À
;C1qa
À/À mice showed significantly reduced grooming activity, more modest skin lesions, and improved survival ( Figures 6M-6O and S6B-S6D). These results support that blocking complement activation via C1qa gene deletion can mitigate the neurodegenerative phenotypes in Grn À/À mice.
Complement Activation as Biomarkers for FTLD with GRN Mutations
Finally, we asked whether microglial and complement activation also contribute to neurodegeneration in FTD patients with (E and F) Western blots (E) and quantification (F) showing the relative abundance of C1qa and C3 proteins in the thalamus of 4-, 9-, and 18-month-old Grn +/+ and Grn À/À mice. *p < 0.05, **p < 0.01, ***p < 0.005, Student's t test. Error bars indicate SEM. n = 3 per age for Grn +/+ and Grn À/À mice. GRN mutations, and if so, whether complement activation could be a potential disease-specific biomarker. To this end, we examined microglial density in the frontal cortex of FTLD patients with GRN mutations (see the Supplemental Information and Table S2 for details). In addition, we included patients with sporadic Alzheimer's disease (AD) and age-matched control cases with no evidence of neurodegeneration (Table S2 ). In control frontal cortex, only few microglia with quiescent morphology were identified ( Figure 7A ). Most microglia in control individuals expressed very low levels of C1qa by immunohistochemistry, and no C1qa was identified near synapses by IEM ( Figures 7B and 7C ). In contrast, FTLD GRN carriers showed a marked increase in microglial density, most prominently affecting layers I-III of the frontal cortex ( Figure 7D ).
Similar to the microglia Grn À/À mouse brain, microglia in FTLD GRN carriers exhibited prominent reactive features and abundant C1qa deposits ( Figure 7E ). Furthermore, immunogold EM identified prominent C1qa signals near or at synapses in the frontal cortex of GRN mutation carriers ( Figure 7F ). To determine whether microglial infiltration in the frontal cortex of FTLD GRN carriers is disease-specific, we examined frontal cortex of AD patients and found that the majority of microglia in these cases appeared to surround the amyloid plaques, where abundant C1qa deposits were found ( Figures 7G and  7H ). On average, the microglial density in the frontal cortex of FTLD GRN carriers showed a 3-to 4-fold increase, whereas the microglial density in AD patients was similar to controls ( Figure 7I ). See also Figure S7 and Tables S2 and S3. The results from the frontal cortex of FTD GRN carriers raise the possibility that complement proteins might be released into the cerebrospinal fluid (CSF) and could serve as biomarkers to predict disease onset and/or progression. Indeed, the utility of CSF was underscored by the $70% drop in PGRN levels in FTLD patients with GRN mutations ( Figure 7J) . Interestingly, the levels of C1qa and C3b showed extensive overlapping in controls and FTLD GRN carriers, indicating that complement protein levels in CSF can be quite variable. However, as disease progressed in FTLD GRN carriers, the levels of C1qa and C3b progressively increased as cognitive functions declined (as determined by mini-mental status exam [MMSE] score) ( Figures 7K and 7L) . In contrast, analyses of previously published CSF data from AD patients (Smyth et al., 1994) showed that C1qa levels in AD patients were significantly lower than those in control and FTLD GRN carriers (controls: 479.5 ± 35.6, FTLD GRN carriers: 442.3 ± 33.0, AD: 268.0 ± 14.2, p < 0.0001, unpaired t test) ( Figure S7A ). Interestingly, as the MMSE declined in AD patients, the CSF C1qa levels showed progressive decrease ( Figure S7B ). Together, these results highlight the distinct differences in the microglia pathology and CSF complement protein levels between FTLD GRN carriers and AD patients.
DISCUSSION PGRN Deficiency and Excessive Microglia Activation in the Aging Brain
Although PGRN has been implicated in lysosomal functions (Belcastro et al., 2011; Zhou et al., 2015) , the exact mechanism remains poorly understood. Several lines of evidence from our study provide key mechanistic insights that PGRN regulates the formation and functions of lysosomes in the microglia. First, transcriptome profiling in Grn
, and Grn À/À aging brains shows that loss of PGRN leads to progressive upregulation of genes that control lysosomal functions and the innate immunity response (Figures 1 and S1 ). Second, confocal microscopic analyses of cultured microglia show that abundant PGRN protein is expressed in the microglia and localized primarily in the Golgi apparatus, Sortilin + vesicles, and lysosomes, suggesting that PGRN might regulate intracellular trafficking and the formation of lysosomes. In support of this idea, Grn À/À microglia exhibit profound lysosomal defects that facilitate more efficient processing via the endolysosomal pathway. Such lysosomal phenotypes, working in conjunction with the upregulation of complement protein C3, promote proteolytic cleavage of C3 by C3 convertase in the lysosomes and lead to a marked increase in the release of biologically active C3 products, including C3b and iC3d (Figures 2, S2 , and S3) (Liszewski et al., 2013; Naito et al., 2012) . Finally, western blot analyses show age-dependent accumulation of C1qa and cleaved C3 products in the synaptosomes of Grn À/À brain.
Consistent with these results, Grn À/À microglia show a marked increase in synaptic pruning activity in microglia-neuron co-cultures and in the ventral thalamus of Grn À/À brain ( Figures 3, 4 , 5, and 6). Together, these results support the idea that PGRN serves as an important ''brake'' to suppress excessive microglia activation in the aging brain by facilitating phagocytosis and endolysosomal trafficking in microglia. Given the robust microglial activation in young mice exposed to the neurotoxin MPTP (Figure 2 ) (Martens et al., 2012) , it is very likely that PGRN deficiency may have a broader role in suppressing microglia activation in other injury paradigms. The identification of aberrant complement activation in Grn À/À microglia provides key mechanistic insights into the pathogenesis of neurodegeneration due to PGRN deficiency. The classical complement pathway serves as an important and well-recognized arm of the innate immunity surveillance system (Walport, 2001) . Several previous studies indicate that complement-mediated synaptic pruning by microglia plays a critical role in the refinement of neural circuits during early postnatal development and in the normal aging process (Schafer et al., 2012; Shi et al., 2015; Stephan et al., 2013; Stevens et al., 2007) . Although it has been postulated that excessive microglial activation may promote neurodegeneration (Aguzzi et al., 2013) (Yin et al., 2010) . This finding provides a neuroanatomical basis for the observed excessive grooming and OCD-like behaviors and is further supported by the well-established role of the ventral thalamus in integrating sensory inputs, frontostriatal circuits, and motor learning (Burguiè re et al., 2015) . While it remains unclear why Grn À/À microglia show a preferential effect on the thalamocortical circuit, given the highly evolutionarily conserved function of this circuit in sensorimotor integration in mammals (Petersen, 2007) , it is possible that similar pathology may contribute to the clinical manifestations in FTLD patients. Consistent with this idea, perseverative and compulsive behaviors are among the most important diagnostic criteria for FTLD (Rascovsky et al., 2011 (Figure 1 ). Since the recent study indicates that TREM2 loss-of-function and TREM2-R47H variant attenuate lipid-sensing ability in microglia to mount a sustained response to neuronal injury in mouse AD models (Wang et al., 2015) , these results raise the possibility that the elevated level of TREM2 in Grn À/À microglia may promote their synaptic pruning activity.
Microglia and Complement Activation as Critical Biomarkers for FTLD
One important neuropathologic feature in the frontal cortex of FTLD patients with GRN mutations is microglial activation, characterized by reactive morphology and excessive complement production ( Figure 7 ). These findings are strikingly similar to those observed in Grn À/À mouse brain and raise the possibility that GRN mutations in FTLD patients may lead to chronic PGRN deficiency in brain tissues, resulting in a de facto PGRN loss-of-function phenotype similar to Grn À/À mice (Baker et al., 2006; Cruts et al., 2006) . Another interesting finding is that CSF samples from FTLD patients with Grn mutations show progressive increases in C1qa and C3b that correlate with cognitive decline (Figure 7 ). In contrast, the histopathologic characteristics of C1qa distribution in the frontal cortex and the positive correlation of complement elevation in the CSF with the decline of MMSE in FTLD GRN carriers are distinctly different from those in AD patients. These results support the disease specificity of complement activation in FTLD (Figures 7 and S7 ) (Smyth et al., 1994) and further indicate that the underlying mechanisms that regulate the complement activation pathway in these two neurodegenerative diseases may be fundamentally different. These results underscore the importance of microglia and complement activation in human FTLD caused by GRN mutations and support the feasibility of developing strategies that target complement proteins as biomarkers to track disease progression and as valid therapeutic targets to mitigate neurodegeneration in FTLD. , and Grn À/À mice, ranging from 2, 6, 9, 12, and 18 months old, was used to characterize age-dependent changes in transcriptomes caused by PGRN deficiency. Mice were perfused with ice-cold PBS, and brains were removed and further dissected to isolate cerebral cortex, hippocampus, and cerebellum. Tissues were homogenized using the Bullet Blender (Next Advance) in Trizol (Invitrogen). RNA integrity was measured by running samples on a Bioanalyzer (Agilent). RNA samples were hybridized to Illumina Mouse8 version 2 microarray chips as previously described (Rosen et al., 2011) . Network analyses were performed as previously described, and gene module merging was accomplished using the WGCNA package in R (Langfelder and Horvath, 2008) . Differentially expressed genes within a given module were compared against the murine background for enrichment within gene ontology (GO) analysis (Table S1 ). These modules were further subjected to system-level functional analyses by determining their topographical overlap.
Human Brain Tissues and Cerebrospinal Fluid Samples
Frozen frontal lobe tissues were procured from controls with no known neurodegenerative diseases, FTLD patients with GRN mutations, and Alzheimer's disease (AD) patients. All cases were clinically and neuropathologically evaluated at the University of California San Francisco (UCSF), Northwestern University, and University of British Columbia. In addition, cerebrospinal fluid (CSF) samples were collected from controls and patients with GRN mutations and clinical diagnosis of FTD at UCSF and Italy. All human tissues and CSF samples were collected with informed consents and institutional review board (IRB) approvals. The demographic information, GRN mutations and pertinent clinical data of these cases are provided in Tables S2 and S3 .
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